{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T05:27:42Z","timestamp":1794288462305,"version":"4.9.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-61431-8","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:47:12Z","timestamp":1752137232000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Host protein ARF1 is a proviral factor for SARS-CoV-2 and a candidate broad-spectrum therapeutic target"],"prefix":"10.1038","volume":"16","author":[{"given":"Cunhuan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1528-3969","authenticated-orcid":false,"given":"Yuan-Qin","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunpeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6750-1465","authenticated-orcid":false,"given":"Hang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3953-3782","authenticated-orcid":false,"given":"Chao","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-4113","authenticated-orcid":false,"given":"Xiulian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7738-1524","authenticated-orcid":false,"given":"Yun-Jia","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"61431_CR1","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou, P. et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270 (2020).","journal-title":"Nature"},{"key":"61431_CR2","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1038\/s41573-023-00672-y","volume":"22","author":"GD Li","year":"2023","unstructured":"Li, G. D., Hilgenfeld, R., Whitley, R. & De Clercq, E. Therapeutic strategies for COVID-19: progress and lessons learned. Nat. Rev. Drug Discov. 22, 449\u2013475 (2023).","journal-title":"Nat. Rev. Drug Discov."},{"key":"61431_CR3","first-page":"162","volume":"21","author":"AM Carabelli","year":"2023","unstructured":"Carabelli, A. M. et al. SARS-CoV-2 variant biology: immune escape, transmission and fitness. Nat. Rev. Microbiol. 21, 162\u2013177 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"61431_CR4","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/s41579-023-00878-2","volume":"21","author":"PV Markov","year":"2023","unstructured":"Markov, P. V. et al. The evolution of SARS-CoV-2. Nat. Rev. Microbiol. 21, 361\u2013379 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"61431_CR5","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1038\/s41586-020-2739-1","volume":"589","author":"Y Finkel","year":"2021","unstructured":"Finkel, Y. et al. The coding capacity of SARS-CoV-2. Nature 589, 125\u2013U254 (2021).","journal-title":"Nature"},{"key":"61431_CR6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson, C. B., Farzan, M., Chen, B. & Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol. 23, 3\u201320 (2022).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61431_CR7","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cell.2020.11.016","volume":"184","author":"L Yan","year":"2021","unstructured":"Yan, L. et al. Cryo-EM structure of an extended SARS-CoV-2 replication and transcription complex reveals an intermediate state in Cap synthesis. Cell 184, 184\u2013193 e110 (2021).","journal-title":"Cell"},{"key":"61431_CR8","doi-asserted-by":"publisher","first-page":"442","DOI":"10.2174\/1568026620666201207095117","volume":"21","author":"DA Sabbah","year":"2021","unstructured":"Sabbah, D. A., Hajjo, R., Bardaweel, S. K. & Zhong, H. A. An Updated review on SARS-CoV-2 main proteinase (M): protein structure and small-molecule inhibitors. Curr. Top. Med Chem. 21, 442\u2013460 (2021).","journal-title":"Curr. Top. Med Chem."},{"key":"61431_CR9","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cell.2021.02.029","volume":"184","author":"JL Schultze","year":"2021","unstructured":"Schultze, J. L. & Aschenbrenner, A. C. COVID-19 and the human innate immune system. Cell 184, 1671\u20131692 (2021).","journal-title":"Cell"},{"key":"61431_CR10","doi-asserted-by":"publisher","first-page":"4217","DOI":"10.1016\/j.csbj.2021.07.023","volume":"19","author":"YQ Min","year":"2021","unstructured":"Min, Y. Q. et al. Immune evasion of SARS-CoV-2 from interferon antiviral system. Comput Struct. Biotechnol. J. 19, 4217\u20134225 (2021).","journal-title":"Comput Struct. Biotechnol. J."},{"key":"61431_CR11","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1016\/j.chom.2021.05.004","volume":"29","author":"SA Lowery","year":"2021","unstructured":"Lowery, S. A., Sariol, A. & Perlman, S. Innate immune and inflammatory responses to SARS-CoV-2: implications for COVID-19. Cell Host Microbe 29, 1052\u20131062 (2021).","journal-title":"Cell Host Microbe"},{"key":"61431_CR12","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1083\/jcb.124.1.55","volume":"124","author":"J Krijnse-Locker","year":"1994","unstructured":"Krijnse-Locker, J., Ericsson, M., Rottier, P. J. & Griffiths, G. Characterization of the budding compartment of mouse hepatitis virus: evidence that transport from the RER to the Golgi complex requires only one vesicular transport step. J. Cell Biol. 124, 55\u201370 (1994).","journal-title":"J. Cell Biol."},{"key":"61431_CR13","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S0065-3527(05)64006-7","volume":"64","author":"CAM de Haan","year":"2005","unstructured":"de Haan, C. A. M. & Rottier, P. J. M. Molecular interactions in the assembly of coronaviruses. Adv. Virus Res. 64, 165\u2013230 (2005).","journal-title":"Adv. Virus Res."},{"key":"61431_CR14","doi-asserted-by":"publisher","first-page":"6523","DOI":"10.1128\/jvi.68.10.6523-6534.1994","volume":"68","author":"J Klumperman","year":"1994","unstructured":"Klumperman, J. et al. Coronavirus M-proteins accumulate in the Golgi-complex beyond the site of virion budding. J. Virol. 68, 6523\u20136534 (1994).","journal-title":"J. Virol."},{"key":"61431_CR15","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1016\/j.virol.2006.11.027","volume":"361","author":"S Stertz","year":"2007","unstructured":"Stertz, S. et al. The intracellular sites of early replication and budding of SARS-coronavirus. Virology 361, 304\u2013315 (2007).","journal-title":"Virology"},{"key":"61431_CR16","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.RA120.016175","volume":"296","author":"B Boson","year":"2021","unstructured":"Boson, B. et al. The SARS-CoV-2 envelope and membrane proteins modulate maturation and retention of the spike protein, allowing assembly of virus-like particles. J. Biol. Chem. 296, 100111 (2021).","journal-title":"J. Biol. Chem."},{"key":"61431_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.jsb.2010.11.021","volume":"174","author":"BW Neuman","year":"2011","unstructured":"Neuman, B. W. et al. A structural analysis of M protein in coronavirus assembly and morphology. J. Struct. Biol. 174, 11\u201322 (2011).","journal-title":"J. Struct. Biol."},{"key":"61431_CR18","doi-asserted-by":"crossref","unstructured":"Voss, D. et al. Studies on membrane topology, N-glycosylation and functionality of SARS-CoV membrane protein. Virol. J. 6, 79 (2009).","DOI":"10.1186\/1743-422X-6-79"},{"key":"61431_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-4939-2438-7_1","volume":"1282","author":"AR Fehr","year":"2015","unstructured":"Fehr, A. R. & Perlman, S. Coronaviruses: an overview of their replication and pathogenesis. Methods Mol. Biol. 1282, 1\u201323 (2015).","journal-title":"Methods Mol. Biol."},{"key":"61431_CR20","doi-asserted-by":"publisher","unstructured":"Dolan, K. A. et al. Structure of SARS-CoV-2 M protein in lipid nanodiscs. Elife. https:\/\/doi.org\/10.7554\/eLife.81702 (2022).","DOI":"10.7554\/eLife.81702"},{"key":"61431_CR21","doi-asserted-by":"publisher","unstructured":"Zhang, Z. K. et al. Structure of SARS-CoV-2 membrane protein essential for virus assembly. Nat. Commun.https:\/\/doi.org\/10.1038\/s41467-022-32019-3 (2022).","DOI":"10.1038\/s41467-022-32019-3"},{"key":"61431_CR22","doi-asserted-by":"publisher","first-page":"11318","DOI":"10.1128\/JVI.01052-08","volume":"82","author":"YL Siu","year":"2008","unstructured":"Siu, Y. L. et al. The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles. J. Virol. 82, 11318\u201311330 (2008).","journal-title":"J. Virol."},{"key":"61431_CR23","doi-asserted-by":"publisher","first-page":"12862","DOI":"10.1074\/jbc.M109.030270","volume":"285","author":"YT Tseng","year":"2010","unstructured":"Tseng, Y. T. et al. Self-assembly of severe acute respiratory syndrome coronavirus membrane protein. J. Biol. Chem. 285, 12862\u201312872 (2010).","journal-title":"J. Biol. Chem."},{"key":"61431_CR24","doi-asserted-by":"publisher","first-page":"2922","DOI":"10.1128\/JVI.77.5.2922-2927.2003","volume":"77","author":"K Narayanan","year":"2003","unstructured":"Narayanan, K., Chen, C. J., Maeda, J. & Makino, S. Nucleocapsid-independent specific viral RNA packaging via viral envelope protein and viral RNA signal. J. Virol. 77, 2922\u20132927 (2003).","journal-title":"J. Virol."},{"key":"61431_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2021.103562","volume":"25","author":"S Nabeel-Shah","year":"2022","unstructured":"Nabeel-Shah, S. et al. SARS-CoV-2 nucleocapsid protein binds host mRNAs and attenuates stress granules to impair host stress response. Iscience 25, 103562 (2022).","journal-title":"Iscience"},{"key":"61431_CR26","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41586-021-03493-4","volume":"594","author":"A Stukalov","year":"2021","unstructured":"Stukalov, A. et al. Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. Nature 594, 246\u2013252 (2021).","journal-title":"Nature"},{"key":"61431_CR27","doi-asserted-by":"publisher","unstructured":"Li, J. et al. Virus-host interactome and proteomic survey reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. Medicine. https:\/\/doi.org\/10.1016\/j.medj.2020.07.002 (2021).","DOI":"10.1016\/j.medj.2020.07.002"},{"key":"61431_CR28","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","volume":"583","author":"DE Gordon","year":"2020","unstructured":"Gordon, D. E. et al. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. Nature 583, 459\u2013468 (2020).","journal-title":"Nature"},{"key":"61431_CR29","doi-asserted-by":"publisher","unstructured":"Min, Y. Q. et al. A new cellular interactome of SARS-CoV-2 nucleocapsid protein and its biological implications. Mol. Cell Proteomics. https:\/\/doi.org\/10.1016\/j.mcpro.2023.100579 (2023).","DOI":"10.1016\/j.mcpro.2023.100579"},{"key":"61431_CR30","doi-asserted-by":"publisher","unstructured":"Feng, K. et al. Interactome profiling reveals interaction of SARS-CoV-2 NSP13 with host factor STAT1 to suppress interferon signaling. J. Mol. Cell Biol. https:\/\/doi.org\/10.1093\/jmcb\/mjab068 (2021).","DOI":"10.1093\/jmcb\/mjab068"},{"key":"61431_CR31","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.cub.2004.06.021","volume":"14","author":"J Faure","year":"2004","unstructured":"Faure, J. et al. ARF1 regulates Nef-induced CD4 degradation. Curr. Biol. 14, 1056\u20131064 (2004).","journal-title":"Curr. Biol."},{"key":"61431_CR32","doi-asserted-by":"publisher","DOI":"10.1126\/science.aac5137","volume":"350","author":"QT Shen","year":"2015","unstructured":"Shen, Q. T., Ren, X., Zhang, R., Lee, I. H. & Hurley, J. H. HIV-1 Nef hijacks clathrin coats by stabilizing AP-1:Arf1 polygons. Science 350, aac5137 (2015).","journal-title":"Science"},{"key":"61431_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.cell.2018.07.004","volume":"174","author":"KL Morris","year":"2018","unstructured":"Morris, K. L. et al. HIV-1 Nefs are cargo-sensitive AP-1 trimerization switches in tetherin downregulation. Cell 174, 659\u2013671 e614 (2018).","journal-title":"Cell"},{"key":"61431_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.cell.2010.03.050","volume":"141","author":"NY Hsu","year":"2010","unstructured":"Hsu, N. Y. et al. Viral Reorganization of the Secretory Pathway Generates Distinct Organelles for RNA Replication. Cell 141, 799\u2013811 (2010).","journal-title":"Cell"},{"key":"61431_CR35","doi-asserted-by":"publisher","first-page":"E3462","DOI":"10.1073\/pnas.1616683114","volume":"114","author":"MD Hansen","year":"2017","unstructured":"Hansen, M. D. et al. Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M. Proc. Natl. Acad. Sci. USA 114, E3462\u2013E3471 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61431_CR36","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1016\/j.apsb.2022.02.011","volume":"12","author":"J Chang","year":"2022","unstructured":"Chang, J. et al. Discovery of ARF1-targeting inhibitor demethylzeylasteral as a potential agent against breast cancer. Acta Pharm. Sin. B 12, 2619\u20132622 (2022).","journal-title":"Acta Pharm. Sin. B"},{"key":"61431_CR37","doi-asserted-by":"publisher","unstructured":"Ma, H. D., Fang, W. Q., Li, Q. M., Wang, Y. T. & Hou, S. X. Arf1 Ablation in colorectal cancer cells activates a super signal complex in DC to enhance anti-tumor immunity. Adv Sci. https:\/\/doi.org\/10.1002\/advs.202305089 (2023).","DOI":"10.1002\/advs.202305089"},{"key":"61431_CR38","doi-asserted-by":"publisher","unstructured":"Wang, G. H. et al. Arf1-mediated lipid metabolism sustains cancer cells and its ablation induces anti-tumor immune responses in mice. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-019-14046-9 (2020).","DOI":"10.1038\/s41467-019-14046-9"},{"key":"61431_CR39","doi-asserted-by":"publisher","unstructured":"Chen, L. F. et al. Sequence-based drug design as a concept in computational drug design. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-39856-w (2023).","DOI":"10.1038\/s41467-023-39856-w"},{"key":"61431_CR40","doi-asserted-by":"publisher","unstructured":"Marques-Pereira, C. et al. SARS-CoV-2 membrane protein: from genomic data to structural new insights. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms23062986 (2022).","DOI":"10.3390\/ijms23062986"},{"key":"61431_CR41","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.bbrc.2014.10.014","volume":"453","author":"N Hayakawa","year":"2014","unstructured":"Hayakawa, N. et al. The ADP-ribosylation factor 1 gene is indispensable for mouse embryonic development after implantation. Biochem. Biophs. Res. Co. 453, 748\u2013753 (2014).","journal-title":"Biochem. Biophs. Res. Co."},{"key":"61431_CR42","doi-asserted-by":"publisher","unstructured":"Mo, Q., Xu, Z., Deng, F., Wang, H. L. & Ning, Y. J. Host restriction of emerging high-pathogenic bunyaviruses via MOV10 by targeting viral nucleoprotein and blocking ribonucleoprotein assembly. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1009129 (2020).","DOI":"10.1371\/journal.ppat.1009129"},{"key":"61431_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43206-1","volume":"14","author":"S Dai","year":"2023","unstructured":"Dai, S. et al. Interactome profiling of Crimean-Congo hemorrhagic fever virus glycoproteins. Nat. Commun. 14, 7365 (2023).","journal-title":"Nat. Commun."},{"key":"61431_CR44","doi-asserted-by":"publisher","unstructured":"Dong, W. J. et al. The K18-human ACE2 transgenic mouse model recapitulates non-severe and severe COVID-19 in response to an infectious dose of the SARS-CoV-2 virus. J. Virol. https:\/\/doi.org\/10.1128\/JVI.00964-21 (2022).","DOI":"10.1128\/JVI.00964-21"},{"key":"61431_CR45","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1038\/s41590-020-0794-2","volume":"21","author":"ES Winkler","year":"2020","unstructured":"Winkler, E. S. et al. SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function (vol 51, pg 831, 2020). Nat. Immunol. 21, 1470\u20131470 (2020).","journal-title":"Nat. Immunol."},{"key":"61431_CR46","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-020-2943-z","volume":"589","author":"J Zheng","year":"2021","unstructured":"Zheng, J. et al. COVID-19 treatments and pathogenesis including anosmia in K18-hACE2 mice. Nature 589, 603 (2021).","journal-title":"Nature"},{"key":"61431_CR47","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abl9929","volume":"7","author":"V Fumagalli","year":"2022","unstructured":"Fumagalli, V. et al. Administration of aerosolized SARS-CoV-2 to K18-hACE2 mice uncouples respiratory infection from fatal neuroinvasion. Sci. Immunol. 7, eabl9929 (2022).","journal-title":"Sci. Immunol."},{"key":"61431_CR48","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1080\/17460441.2022.1995352","volume":"17","author":"CBP Da Costa","year":"2022","unstructured":"Da Costa, C. B. P. et al. Using in vivo animal models for studying SARS-CoV-2. Expert Opin. Drug Dis. 17, 121\u2013137 (2022).","journal-title":"Expert Opin. Drug Dis."},{"key":"61431_CR49","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/nrm3117","volume":"12","author":"JG Donaldson","year":"2011","unstructured":"Donaldson, J. G. & Jackson, C. L. ARF family G proteins and their regulators: roles in membrane transport, development and disease. Nat. Rev. Mol. Cell Biol. 12, 362\u2013375 (2011).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61431_CR50","doi-asserted-by":"publisher","first-page":"3488","DOI":"10.1091\/mbc.e08-04-0373","volume":"19","author":"J Chun","year":"2008","unstructured":"Chun, J., Shapovalova, Z., Dejgaard, S. Y., Presley, J. F. & Melancon, P. Characterization of class I and II ADP-ribosylation factors (Arfs) in live cells: GDP-bound class II Arfs associate with the ER-Golgi intermediate compartment independently of GBF1. Mol. Biol. Cell 19, 3488\u20133500 (2008).","journal-title":"Mol. Biol. Cell"},{"key":"61431_CR51","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1016\/S0021-9258(17)42277-0","volume":"269","author":"C Dascher","year":"1994","unstructured":"Dascher, C. & Balch, W. E. Dominant inhibitory mutants of Arf1 block endoplasmic-reticulum to Golgi transport and trigger disassembly of the Golgi-apparatus. J. Biol. Chem. 269, 1437\u20131448 (1994).","journal-title":"J. Biol. Chem."},{"key":"61431_CR52","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.str.2008.10.020","volume":"17","author":"YZ Liu","year":"2009","unstructured":"Liu, Y. Z., Kahn, R. A. & Prestegard, J. H. Structure and membrane interaction of myristoylated ARF1. Structure 17, 79\u201387 (2009).","journal-title":"Structure"},{"key":"61431_CR53","doi-asserted-by":"publisher","unstructured":"Muccini, A. J., Gustafson, M. A. & Fromme, J. C. Structural basis for activation of Arf1 at the Golgi complex. Cell Rep. https:\/\/doi.org\/10.1016\/j.celrep.2022.111282 (2022).","DOI":"10.1016\/j.celrep.2022.111282"},{"key":"61431_CR54","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42150-4","volume":"14","author":"M Hirschenberger","year":"2023","unstructured":"Hirschenberger, M. et al. ARF1 prevents aberrant type I interferon induction by regulating STING activation and recycling. Nat. Commun. 14, 6770 (2023).","journal-title":"Nat. Commun."},{"key":"61431_CR55","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1242\/jcs.03019","volume":"119","author":"C Appenzeller-Herzog","year":"2006","unstructured":"Appenzeller-Herzog, C. & Hauri, H. P. The ER-Golgi intermediate compartment (ERGIC): in search of its identity and function. J. Cell Sci. 119, 2173\u20132183 (2006).","journal-title":"J. Cell Sci."},{"key":"61431_CR56","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1091\/mbc.e04-12-1042","volume":"16","author":"LA Volpicelli-Daley","year":"2005","unstructured":"Volpicelli-Daley, L. A., Li, Y., Zhang, C. J. & Kahn, R. A. Isoform-selective effects of the depletion of ADP-ribosylation factors 1-5 on membrane traffic. Mol. Biol. Cell 16, 4495\u20134508 (2005).","journal-title":"Mol. Biol. Cell"},{"key":"61431_CR57","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1111\/cmi.12572","volume":"18","author":"R Farhat","year":"2016","unstructured":"Farhat, R. et al. Identification of class II ADP-ribosylation factors as cellular factors required for hepatitis C virus replication. Cell Microbiol 18, 1121\u20131133 (2016).","journal-title":"Cell Microbiol"},{"key":"61431_CR58","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1099\/jgv.0.001099","volume":"99","author":"J Ferlin","year":"2018","unstructured":"Ferlin, J. et al. Investigation of the role of GBF1 in the replication of positive-sense single-stranded RNA viruses. J. Gen. Virol. 99, 1086\u20131096 (2018).","journal-title":"J. Gen. Virol."},{"key":"61431_CR59","doi-asserted-by":"publisher","unstructured":"Miura, K. et al. Distinct motifs in the E protein are required for SARS-CoV-2 virus particle formation and lysosomal deacidification in host cells. J. Virol. https:\/\/doi.org\/10.1128\/jvi.00426-23 (2023).","DOI":"10.1128\/jvi.00426-23"},{"key":"61431_CR60","doi-asserted-by":"publisher","unstructured":"Plescia, C. B. et al. SARS-CoV-2 viral budding and entry can be modeled using BSL-2 level virus-like particles. J. Biol. Chem. https:\/\/doi.org\/10.1074\/jbc.RA120.016148 (2021).","DOI":"10.1074\/jbc.RA120.016148"},{"key":"61431_CR61","doi-asserted-by":"publisher","unstructured":"Xu, R. D., Shi, M. F., Li, J., Song, P. & Li, N. Construction of SARS-CoV-2 virus-like particles by mammalian expression system. Front. Bioeng. Biotech. https:\/\/doi.org\/10.3389\/fbioe.2020.00862 (2020).","DOI":"10.3389\/fbioe.2020.00862"},{"key":"61431_CR62","doi-asserted-by":"publisher","unstructured":"Yang, Q. et al. Role for glycans and calnexin-calreticulin chaperones in SARS-CoV-2 Spike maturation and viral infectivity. Sci. Adv. https:\/\/doi.org\/10.1126\/sciadv.abq8678 (2022).","DOI":"10.1126\/sciadv.abq8678"},{"key":"61431_CR63","doi-asserted-by":"publisher","unstructured":"Kumar, B. et al. Assembly and Entry Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2): Evaluation Using Virus-like Particles. Cells. https:\/\/doi.org\/10.3390\/cells10040853 (2021).","DOI":"10.3390\/cells10040853"},{"key":"61431_CR64","doi-asserted-by":"publisher","unstructured":"Dey, D. et al. A single C-terminal residue controls SARS-CoV-2 spike trafficking and incorporation into VLPs. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-44076-3 (2023).","DOI":"10.1038\/s41467-023-44076-3"},{"key":"61431_CR65","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1242\/jcs.111.9.1277","volume":"111","author":"C Vasudevan","year":"1998","unstructured":"Vasudevan, C. et al. The distribution and translocation of the G protein ADP-ribosylation factor 1 in live cells is determined by its GTPase activity. J. Cell Sci. 111, 1277\u20131285 (1998).","journal-title":"J. Cell Sci."},{"key":"61431_CR66","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nchembio.144","volume":"5","author":"JB Saenz","year":"2009","unstructured":"Saenz, J. B. et al. Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat. Chem. Biol. 5, 157\u2013165 (2009).","journal-title":"Nat. Chem. Biol."},{"key":"61431_CR67","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1128\/JVI.02684-09","volume":"84","author":"L van der Linden","year":"2010","unstructured":"van der Linden, L., van der Schaar, H. M., Lanke, K. H., Neyts, J. & van Kuppeveld, F. J. Differential effects of the putative GBF1 inhibitors Golgicide A and AG1478 on enterovirus replication. J. Virol. 84, 7535\u20137542 (2010).","journal-title":"J. Virol."},{"key":"61431_CR68","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.tips.2017.01.003","volume":"38","author":"G Guidotti","year":"2017","unstructured":"Guidotti, G., Brambilla, L. & Rossi, D. Cell-penetrating peptides: from basic research to clinics. Trends Pharm. Sci. 38, 406\u2013424 (2017).","journal-title":"Trends Pharm. Sci."},{"key":"61431_CR69","doi-asserted-by":"publisher","unstructured":"Fang, Y. et al. Antiviral peptides targeting the helicase activity of Enterovirus nonstructural protein 2C. J. Virol. https:\/\/doi.org\/10.1128\/JVI.02324-20 (2021).","DOI":"10.1128\/JVI.02324-20"},{"key":"61431_CR70","doi-asserted-by":"publisher","unstructured":"Zhang, Y. et al. Myr-Arf1 conformational flexibility at the membrane surface sheds light on the interactions with ArfGAP ASAP1. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-43008-5 (2023).","DOI":"10.1038\/s41467-023-43008-5"},{"key":"61431_CR71","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1146\/annurev.bi.63.070194.004253","volume":"63","author":"DR Johnson","year":"1994","unstructured":"Johnson, D. R., Bhatnagar, R. S., Knoll, L. J. & Gordon, J. I. Genetic and biochemical-studies of protein N-myristoylation. Annu. Rev. Biochem. 63, 869\u2013914 (1994).","journal-title":"Annu. Rev. Biochem."},{"key":"61431_CR72","doi-asserted-by":"publisher","unstructured":"Beauchamp, E. et al. Targeting N-myristoylation for therapy of B-cell lymphomas. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-020-18998-1 (2020).","DOI":"10.1038\/s41467-020-18998-1"},{"key":"61431_CR73","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1073\/pnas.2009799117","volume":"117","author":"M Imai","year":"2020","unstructured":"Imai, M. et al. Syrian hamsters as a small animal model for SARS-CoV-2 infection and countermeasure development. Proc. Natl. Acad. Sci. USA 117, 16587\u201316595 (2020).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"61431_CR74","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1038\/s41586-020-2342-5","volume":"583","author":"SF Sia","year":"2020","unstructured":"Sia, S. F. et al. Pathogenesis and transmission of SARS-CoV-2 in golden hamsters. Nature 583, 834 (2020).","journal-title":"Nature"},{"key":"61431_CR75","doi-asserted-by":"publisher","first-page":"2428","DOI":"10.1093\/cid\/ciaa325","volume":"71","author":"JFW Chan","year":"2020","unstructured":"Chan, J. F. W. et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in a Golden Syrian Hamster model: implications for disease pathogenesis and transmissibility. Clin. Infect. Dis. 71, 2428\u20132446 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"61431_CR76","first-page":"785","volume":"609","author":"H Chu","year":"2022","unstructured":"Chu, H. et al. Coronaviruses exploit a host cysteine-aspartic protease for replication. Nature 609, 785 (2022).","journal-title":"Nature"},{"key":"61431_CR77","doi-asserted-by":"publisher","unstructured":"Gourdelier, M. et al. Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles. Sci. Rep. 12, https:\/\/doi.org\/10.1038\/s41598-022-18681-z (2022).","DOI":"10.1038\/s41598-022-18681-z"},{"key":"61431_CR78","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03168-21","volume":"13","author":"Z Yuan","year":"2021","unstructured":"Yuan, Z. et al. The E3 ubiquitin ligase RNF5 facilitates SARS-CoV-2 membrane protein-mediated virion release. mBio 13, e0316821 (2021).","journal-title":"mBio"},{"key":"61431_CR79","doi-asserted-by":"publisher","unstructured":"Naskalska, A. et al. Functional severe acute respiratory syndrome Coronavirus 2 virus-like particles from insect cells. Front. Microbiol. https:\/\/doi.org\/10.3389\/fmicb.2021.732998 (2021).","DOI":"10.3389\/fmicb.2021.732998"},{"key":"61431_CR80","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/all.15091","volume":"77","author":"IC Yilmaz","year":"2022","unstructured":"Yilmaz, I. C. et al. Development and preclinical evaluation of virus-like particle vaccine against COVID-19 infection. Allergy 77, 258\u2013270 (2022).","journal-title":"Allergy"},{"key":"61431_CR81","doi-asserted-by":"publisher","unstructured":"Li, Y. H. et al. A substitution at the cytoplasmic tail of the spike protein enhances SARS-CoV-2 infectivity and immunogenicity. Ebiomedicine. https:\/\/doi.org\/10.1016\/j.ebiom.2024.105437 (2024).","DOI":"10.1016\/j.ebiom.2024.105437"},{"key":"61431_CR82","doi-asserted-by":"publisher","unstructured":"Gullberg, R. C. & Frydman, J. Novel mode of nanoluciferase packaging in SARS-CoV-2 virions and VLPs provides versatile reporters for virus production. Viruses. https:\/\/doi.org\/10.3390\/v15061335 (2023).","DOI":"10.3390\/v15061335"},{"key":"61431_CR83","doi-asserted-by":"publisher","unstructured":"Jaron, M. et al. Baculovirus-free SARS-CoV-2 virus-like particle production in insect cells for rapid neutralization assessment. Viruses. https:\/\/doi.org\/10.3390\/v14102087 (2022).","DOI":"10.3390\/v14102087"},{"key":"61431_CR84","doi-asserted-by":"publisher","unstructured":"Sultana, R. & Stahelin, R. V. Strengths and limitations of SARS-CoV-2 virus-like particle systems. Virology. https:\/\/doi.org\/10.1016\/j.virol.2024.110285 (2025).","DOI":"10.1016\/j.virol.2024.110285"},{"key":"61431_CR85","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrm1910","volume":"7","author":"C D\u2019Souza-Schorey","year":"2006","unstructured":"D\u2019Souza-Schorey, C. & Chavrier, P. ARF proteins: roles in membrane traffic and beyond. Nat. Rev. Mol. Cell Biol. 7, 347\u2013358 (2006).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"61431_CR86","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1042\/BST0331269","volume":"33","author":"RA Kahn","year":"2005","unstructured":"Kahn, R. A. et al. Arf family GTPases: roles in membrane traffic and microtubule dynamics. Biochem. Soc. T 33, 1269\u20131272 (2005).","journal-title":"Biochem. Soc. T"},{"key":"61431_CR87","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1091\/mbc.E20-10-0664","volume":"32","author":"LL Thomas","year":"2021","unstructured":"Thomas, L. L., Highland, C. M. & Fromme, J. C. Arf1 orchestrates Rab GTPase conversion at the trans-Golgi network. Mol. Biol. Cell 32, 1104\u20131120 (2021).","journal-title":"Mol. Biol. Cell"},{"key":"61431_CR88","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1016\/S0955-0674(00)00119-8","volume":"12","author":"JG Donaldson","year":"2000","unstructured":"Donaldson, J. G. & Jackson, C. L. Regulators and effectors of the ARF GTPases. Curr. Opin. Cell Biol. 12, 475\u2013482 (2000).","journal-title":"Curr. Opin. Cell Biol."},{"key":"61431_CR89","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/235170","volume":"2015","author":"J Gamara","year":"2015","unstructured":"Gamara, J., Chouinard, F., Davis, L., Aoudjit, F. & Bourgoin, S. G. Regulators and effectors of Arf GTPases in neutrophils. J. Immunol. Res. 2015, 235170 (2015).","journal-title":"J. Immunol. Res."},{"key":"61431_CR90","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.tibs.2004.08.007","volume":"29","author":"HW Shin","year":"2004","unstructured":"Shin, H. W. & Nakayama, K. Dual control of membrane targeting by PtdIns(4)P and ARF. Trends Biochem. Sci. 29, 513\u2013515 (2004).","journal-title":"Trends Biochem. Sci."},{"key":"61431_CR91","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/S0092-8674(00)00060-X","volume":"102","author":"HRB Pelham","year":"2000","unstructured":"Pelham, H. R. B. & Rothman, J. E. The debate about transport in the Golgi\u2014Two sides of the same coin?. Cell 102, 713\u2013719 (2000).","journal-title":"Cell"},{"key":"61431_CR92","doi-asserted-by":"publisher","first-page":"e1007086","DOI":"10.1371\/journal.ppat.1007086","volume":"14","author":"S Banerjee","year":"2018","unstructured":"Banerjee, S. et al. Hijacking of multiple phospholipid biosynthetic pathways and induction of membrane biogenesis by a picornaviral 3CD protein. PLoS Pathog. 14, e1007086 (2018).","journal-title":"PLoS Pathog."},{"key":"61431_CR93","doi-asserted-by":"publisher","first-page":"11940","DOI":"10.1128\/JVI.01244-09","volume":"83","author":"KHW Lanke","year":"2009","unstructured":"Lanke, K. H. W. et al. GBF1, a guanine nucleotide exchange factor for Arf, is crucial for Coxsackievirus B3 RNA replication. J. Virol. 83, 11940\u201311949 (2009).","journal-title":"J. Virol."},{"key":"61431_CR94","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02005-21","volume":"96","author":"MC Gimenez","year":"2022","unstructured":"Gimenez, M. C. et al. Rab1b-GBF1-ARF1 secretory pathway axis is required for birnavirus replication. J. Virol. 96, e0200521 (2022).","journal-title":"J. Virol."},{"key":"61431_CR95","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1111\/tra.12305","volume":"16","author":"NG Iglesias","year":"2015","unstructured":"Iglesias, N. G. et al. Dengue virus uses a non-canonical function of the host GBF1-Arf-COPI system for capsid protein accumulation on lipid droplets. Traffic 16, 962\u2013977 (2015).","journal-title":"Traffic"},{"key":"61431_CR96","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.02193-21","volume":"96","author":"L Zhang","year":"2022","unstructured":"Zhang, L. et al. ARF1 with Sec7 domain-dependent GBF1 activates coatomer protein I To support classical swine fever virus entry. J. Virol. 96, e0219321 (2022).","journal-title":"J. Virol."},{"key":"61431_CR97","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/boc.201700042","volume":"109","author":"B Kaczmarek","year":"2017","unstructured":"Kaczmarek, B., Verbavatz, J. M. & Jackson, C. L. GBF1 and Arf1 function in vesicular trafficking, lipid homoeostasis and organelle dynamics. Biol. Cell 109, 391\u2013399 (2017).","journal-title":"Biol. Cell"},{"key":"61431_CR98","doi-asserted-by":"publisher","unstructured":"Jiang, Z. B. et al. Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8 T cells. Pharmacol. Res. https:\/\/doi.org\/10.1016\/j.phrs.2021.105656 (2021).","DOI":"10.1016\/j.phrs.2021.105656"},{"key":"61431_CR99","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1091\/mbc.e13-06-0335","volume":"25","author":"S Schlienger","year":"2014","unstructured":"Schlienger, S., Campbell, S. & Claing, A. ARF1 regulates the Rho\/MLC pathway to control EGF-dependent breast cancer cell invasion. Mol. Biol. Cell 25, 17\u201329 (2014).","journal-title":"Mol. Biol. Cell"},{"key":"61431_CR100","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/kjm2.12253","volume":"36","author":"LG Zhao","year":"2020","unstructured":"Zhao, L. G., Wang, J., Li, J. & Li, Q. F. miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer. Kaohsiung J. Med. Sci. 36, 799\u2013807 (2020).","journal-title":"Kaohsiung J. Med. Sci."},{"key":"61431_CR101","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1080\/21655979.2020.1863035","volume":"12","author":"J Cheng","year":"2021","unstructured":"Cheng, J., Lou, Y. H. & Jiang, K. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b\/ARF1 axis. Bioengineered 12, 96\u2013107 (2021).","journal-title":"Bioengineered"},{"key":"61431_CR102","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1038\/nprot.2013.143","volume":"8","author":"FA Ran","year":"2013","unstructured":"Ran, F. A. et al. Genome engineering using the CRISPR-Cas9 system. Nat. Protoc. 8, 2281\u20132308 (2013).","journal-title":"Nat. Protoc."},{"key":"61431_CR103","doi-asserted-by":"publisher","unstructured":"Chang, M. et al. Host factor MxA restricts Dabie bandavirus infection by targeting the viral NP protein to inhibit NP-RdRp interaction and ribonucleoprotein activity. J. Virol. https:\/\/doi.org\/10.1128\/jvi.01568-23 (2023).","DOI":"10.1128\/jvi.01568-23"},{"key":"61431_CR104","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.addr.2012.09.039","volume":"65","author":"XY Chen","year":"2013","unstructured":"Chen, X. Y., Zaro, J. L. & Shen, W. C. Fusion protein linkers: property, design and functionality. Adv. Drug Deliv. Rev. 65, 1357\u20131369 (2013).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"61431_CR105","doi-asserted-by":"publisher","first-page":"9691","DOI":"10.1074\/jbc.RA120.013973","volume":"295","author":"YQ Min","year":"2020","unstructured":"Min, Y. Q., Ning, Y. J., Wang, H. & Deng, F. A RIG-I-like receptor directs antiviral responses to a bunyavirus and is antagonized by virus-induced blockade of TRIM25-mediated ubiquitination. J. Biol. Chem. 295, 9691\u20139711 (2020).","journal-title":"J. Biol. Chem."},{"key":"61431_CR106","first-page":"389","volume":"9","author":"YJ Ning","year":"2018","unstructured":"Ning, Y. J. et al. Ebola virus mucin-like glycoprotein (Emuc) induces remarkable acute inflammation and tissue injury: evidence for Emuc pathogenicity in vivo. Protein Cell 9, 389\u2013393 (2018).","journal-title":"Protein Cell"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61431-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61431-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T04:28:02Z","timestamp":1757219282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-61431-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["61431"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-61431-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3812840\/v1","asserted-by":"object"}]},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y.-Q.M., C.Z., X.S. and Y.-J.N. have filed a patent application for the antiviral PEP17 (CN116478301A) as inventors, while all other authors declare that they have no conflicts of interest with the contents of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6326"}}